Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma

Gallbladder carcinoma (GBC) is a rare and highly aggressive tumor. Early diagnosis is challenging, which results in a poor prognosis using systemic therapy. Recent studies have identified a subset of GBC patients with HER2 gene (ERBB2) amplification that could benefit from HER2-targeted therapy. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Minfeng, Lv, Jieqing, Xu, Guangen, Wang, Wei, Jing, Yuanming, Sun, Aijing, Lu, Zengxin, Wu, Xue, Liu, Yichuan, Shao, Yang W., Liu, Fang, Tao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567708/
https://www.ncbi.nlm.nih.gov/pubmed/31106632
http://dx.doi.org/10.1177/0300060519847796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567708/
https://www.ncbi.nlm.nih.gov/pubmed/31106632
http://dx.doi.org/10.1177/0300060519847796

Ejemplares similares